NEWS

​Agilex Biolabs   →  News
05
Jan
Date January 5, 2021
Categories Company News

Agilex Biolabs takes delivery of two Sciex API 6500+™ LC-MS/MS systems

Agilex Biolabs is the leading bioanalytical laboratory in Asia-Pacific with the most advanced platforms for sensitive technologies. They include Sciex API 6500+ LC-MS/MS, Sciex API 4000 LC-MS/MS systems; Gyrolab™ Xplore, Luminex MAGPIX xPONENT ™, MSD Quickplex 120 and BD FACSymphony™ A3 20 colour flow cytometry analysers, so we have the capability to deliver any sized project.
Read More
Author Agilex Biolabs
01
Nov
Date November 1, 2020
Categories Client News

Client News: Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough

Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company to reach clinical development.
Read More
Author Agilex Biolabs
22
Aug
Date August 22, 2020
Categories Webinars

Endpoints News Webinar: Why Australia is the World’s Leading Early Phase Destination – plus up to 50% cost savings

Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs Increasingly Sponsors are wanting to be actively involved in the core clinical partner selection because they matter to the success of their clinical research.
Read More
Author Agilex Biolabs
20
Aug
Agilex Biolabs
Date August 20, 2020
Categories Transcripts, Webinars

Endpoints Webinar (transcript): Why Australia is the World Leader for Phase 1 Trials

Hi, everyone. I'm Arsalan Arif, the publisher of Endpoints News, and I'm pleased to be your moderator today. Today's webinar is sponsored by Agilex Biolabs in Australia. Our topic is Why Australia is the World's Leading Early Phase Destination - Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs. I'm joined by two great guests today. Kurt Sales, the Director of Immunoassay at Agilex Biolabs, and Jane Kelly, the CEO of CMAX Clinical Research.
Read More
Author Agilex Biolabs
30
Jul
Date July 30, 2020
Categories Webinars

Endpoints Webinar: How Easy is it to Move Your Trial to Australia?

Gathering together the key clinical service providers for a trial can be a daunting process – especially if you are going off-shore to reactivate trials or start new trials to make up for COVID delays.

However, Australia offers a refreshingly streamlined process because of its group of proven top-tier providers that regularly work together so are fully engaged and in sync with processes and each other’s requirements and capabilities. This makes setting up trials in Australia a smooth, professional, and rapid process for biotechs. This webinar looks at how moving trials to Australia could be much easier than you think.
Read More
Author Agilex Biolabs
1 … 7 8 9 10 11